A+ = 95.0+
A = 91.0-94.9
A- = 88.0-90.9
B+ = 85.0-87.9
B = 81.0-84.9
B- = 78.0-80.9
A = 91.0-94.9
A- = 88.0-90.9
B+ = 85.0-87.9
B = 81.0-84.9
B- = 78.0-80.9
C+ = 75.0-77.9
C = 71.0-74.9
C- = 68.0-70.9
D+ = 65.0-67.9
D = 61.0-64.9
D- = 58.0-60.9
F = <58.0
C = 71.0-74.9
C- = 68.0-70.9
D+ = 65.0-67.9
D = 61.0-64.9
D- = 58.0-60.9
F = <58.0
Based on KLAS' Decision Insights data, the market energy indicator reflects the frequency with which a vendor is seriously considered and replaced compared to what would be expected based on the number of vendors in the market and the number of purchase decisions recorded.
Market average: 81.4
Software average: 82.4
Overall performance score (100-point scale) |
Trend (2020-2021) |
Total evaluations |
Culture
|
Loyalty
|
Operations
|
Product
|
Relationship
|
Value
|
||
|
Bluesight
Kit Check Bluesight for Controlled Substances 
|
90.0 |
0%
|
n=39
|
B+
|
A
|
A-
|
B+
|
A-
|
A
|
|
| |
|
|
|
|
||||||
|
Omnicell
Analytics |
69.7 |
0%
|
n=25
|
D+
|
C-
|
C
|
C
|
C
|
D
|
|
| |
|
|
|
|
||||||
|
Bluesight
Medacist RxAuditor |
68.9 |
0%
|
n=21
|
B-
|
F
|
C
|
D
|
C+
|
C+
|
|
50.0 |
100.0 |
|||||||||
culture
B+
loyalty
A
operations
A-
product
B+
relationship
A-
value
A
Omnicell
Analytics
Analytics
69.7
n=25
culture
D+
loyalty
C-
operations
C
product
C
relationship
C
value
D
Bluesight
Medacist RxAuditor
Medacist RxAuditor
68.9
n=21
culture
B-
loyalty
F
operations
C
product
D
relationship
C+
value
C+
Solutions Not Ranked
Ordered alphabetically
L
|
Overall Performance Score (100-point scale) |
Total evaluations |
Culture
|
Loyalty
|
Operations
|
Product
|
Relationship
|
Value
|
|
|
HelioMetrics
Drug Diversion Analytics L |
76.5 |
n=9
|
C-
|
C+
|
C
|
C+
|
B-
|
B
|
| |
|
|
|
|
||||
|
Imprivata
FairWarning Drug Diversion Monitoring L |
93.9 |
n=13
|
A+
|
A+
|
A-
|
A-
|
A
|
A+
|
| |
|
|
|
|
||||
|
Wolters Kluwer
Invistics Flowlytics L |
80.2 |
n=6
|
C
|
B
|
C+
|
C+
|
A-
|
B+
|
L
&nbps;
HelioMetrics
Drug Diversion Analytics L
Drug Diversion Analytics L
76.5
n=9
n=9
culture
C-
loyalty
C+
operations
C
product
C+
relationship
B-
value
B
Imprivata
FairWarning Drug Diversion Monitoring L
FairWarning Drug Diversion Monitoring L
93.9
n=13
n=13
culture
A+
loyalty
A+
operations
A-
product
A-
relationship
A
value
A+
Wolters Kluwer
Invistics Flowlytics L
Invistics Flowlytics L
80.2
n=6
n=6
culture
C
loyalty
B
operations
C+
product
C+
relationship
A-
value
B+
